How effective is nivolumab + brentuximab vedotin as a consolidation therapy for Hodgkin lymphoma?
During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma Hub spoke to Alex Herrera, City of Hope Comprehensive...
"The Lymphoma Hub allows you to navigate the most relevant and up-to-date information in lymphoma and CLL. From recently published papers to on-site interviews, we aim to deliver valuable data to all physicians practicing hemato-oncology."